Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis

Area of Science:

• Molecular biology
• Immunology
• Neurology

Background:

• Inflammatory myopathies, including dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM), have complex molecular underpinnings.
• Understanding the specific pathways involved is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the molecular mechanisms driving the pathogenesis of DM, PM, and IBM.
• To identify key differentially expressed genes and signaling pathways in affected muscle tissues.

Main Methods:

• Microarray analysis of microdissected muscle fibers from 15 patients and 5 controls.
• Validation of candidate genes using immunohistochemistry on muscle biopsies.
• Analysis of altered pathways in human myotube cultures.

Main Results:

• Upregulation of viral and nucleic acid recognition genes observed in all three myopathies.
• Significant upregulation of retinoic acid-inducible gene 1 (RIG-I) and DDX60 in DM, with RIG-I overexpression confirmed by immunohistochemistry.
• RIG-I ligand stimulation induced interferon-β (IFNβ) secretion and class I MHC upregulation in human myotubes via IFNβ-dependent and TLR3-independent mechanisms.

Conclusions:

• RIG-I-mediated innate immunity plays a significant role in the pathogenesis of DM.
• This pathway is not a major contributor to the pathogenesis of PM or IBM.
• Findings highlight RIG-I as a potential therapeutic target for dermatomyositis.